The Centers for Medicare & Medicaid Services (CMS) has increased the Medicare payment rate for the administration of monoclonal antibodies for the treatment of beneficiaries with COVID-19.
This content is restricted to members.
CMS Announces Increased Reimbursement For Monoclonal Antibody Administration
For CFOs, billing & coding staff
